The progress of molecular-targeted therapeutic drugs in non-small cell lung cancer
10.3969/j.issn.1000-8179.2015.17.714
- VernacularTitle:非小细胞肺癌分子靶向治疗药物的现状及进展
- Author:
Jingsi JIN
;
Jinzhao HE
;
Liming ZHOU
- Publication Type:Journal Article
- Keywords:
non-small cell lung cancer;
molecular-targeted therapeutic drugs;
individualized treatment
- From:
Chinese Journal of Clinical Oncology
2015;(17):881-885
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer is ranked the first among all malignant neoplastic diseases because of its high morbidity and mortality rate. Thus, lung cancer seriously threatens human health. More than 80%of lung cancer cases are non-small cell lung cancer (NSCLC). Unfortunately, the majority of NSCLC patients are already at the terminal stage of the disease when they seek medical attention. Such patients miss the optimal opportunity of surgery;thus, medical treatment becomes the main choice for them. Recently, molecular-target-ed therapy has made tremendous progress in clinical practice and provides a new potential treatment for patients at the terminal stage. In this review, the authors introduced some molecular-targeted therapeutic drugs to provide benefits for the individualized treatment of patients.
